Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
ESET’s Jake Moore used smart glasses, deepfakes and face swaps to ‘hack’ widely-used facial recognition systems – and he'll demo it all at RSAC 2026 The cybersecurity implications of the war in the ...
Choose a SQL Server trial, edition, tool, or connector that best meets your data and workload needs. Accelerate AI development with SQL Server 2025, the AI-ready enterprise database with best-in-class ...
Web application for sizing Oracle Exadata X11M on-premises systems based on workload data extracted from Oracle Enterprise Manager (OEM) 24ai. Analyzes current database workloads (CPU, memory, storage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results